[1]孙莹莹,常丽辉,苗文霞.老年急性ST段抬高型心肌梗死患者血清RF，Cys-C水平与直接PCI术后无复流的关系[J].现代检验医学杂志,2022,37(02):184-189.[doi:10.3969/j.issn.1671-7414.2022.02.037]
　SUN Ying-ying,CHANG Li-hui,MIAO Wen-xia.Correlation between Serum RF, Cys-C Levels and No-reflow after Primary PCI in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Modern Laboratory Medicine,2022,37(02):184-189.[doi:10.3969/j.issn.1671-7414.2022.02.037]
点击复制

老年急性ST段抬高型心肌梗死患者血清RF，Cys-C水平与直接PCI术后无复流的关系()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年02期
页码:
184-189
栏目:
检验与临床
出版日期:
2022-03-15

文章信息/Info

Title:
Correlation between Serum RF, Cys-C Levels and No-reflow after Primary PCI in Elderly Patients with Acute ST-segment Elevation Myocardial Infarction
文章编号:
1671-7414（2022）02-184-06
作者:
孙莹莹; 常丽辉; 苗文霞
（河北省邯郸市中心医院心内三科，河北邯郸 056008)
Author(s):
SUN Ying-ying;  CHANG Li-hui;  MIAO Wen-xia
(the Third Department of Internal Medicine-Cardiovascular, Handan Central Hospital of Hebei Province, Hebei Handan 056008, China)
关键词:
急性ST段抬高型心肌梗死; 类风湿因子; 胱抑素-C; 冠状动脉介入; 无复流
分类号:
R542.22；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.02.037
文献标志码:
A
摘要:
目的　分析血清类风湿因子（rheumatoid factor, RF），胱抑素-C（cystatin C, Cys-C）水平与老年急性ST 段抬高型心肌梗死（ST-segment elevation myocardial infarction, STEMI）患者直接经皮冠状动脉介入（percutaneous coronary intervention, PCI）术后无复流的关系。方法　选取邯郸市中心医院于2018 年12 月～ 2019 年12 月收治的232 例行直接PCI 术的老年STEMI 患者，术后根据心肌梗死溶栓治疗（TIMI）血流分级将患者分为无复流组（47 例）和正常血流组（185 例），比较两组患者术前血清RF 和Cys-C 水平及一般临床资料的差异，分析老年STEMI 患者直接PCI 术后无复流的危险因素，分析RF 和Cys-C 对患者无复流的预测价值。结果　无复流组患者的血清RF（18.34±7.65 IU/ml vs8.47±4.16 IU/ml），Cys C（1.58±0.54mg/L vs 0.87±0.32mg/L）及支架置入数目（3.15±1.43 个 vs 2.02±1.12 个），多支血管病变比例
[30（63.83%） vs 66（35.68%）]，糖尿病比例
[33（70.21%） vs 77（41.62%）] 明显高于正常血流组，差异均有统计学意义（χ2/t=11.954~111.607，均P <0.05）。Logistic 多因素回归分析显示年龄、糖尿病、RF 和Cys-C 是老年STEMI 患者直接PCI 术后无复流的危险因素（OR=1.893~3.025，均P< 0.05）。RF 和Cys-C 预测行直接PCI 术的老年STEMI 患者术后无复流的受试者工作特征（ROC）曲线下面积（AUC）分别为0.864 和0.821，二者联合检测的AUC 为0.918，高于RF 和Cys-C 任一单项指标。结论　老年STEMI 直接PCI 术后无复流患者血清RF 和Cys-C 水平升高，且二者均是无复流发生的危险因素，有助于早期识别无复流。
Abstract:
Objective　To analyze the relationship between serum rheumatoid factor (RF), cystatin -C (Cys-C) levels and no reflow after direct percutaneous coronary intervention (PCI) in elderly patients with acute ST-segment elevation myocardial infarction (STEMI). Methods　A total of 232 elderly STEMI patients undergoing direct PCI were selected from Handan Central Hospital from December 2018 to December 2019. According to postoperative myocardial infarction (TIMI) flow thrombolysis treatment classification，the patients were divided into the no-reflow group (47 cases) and normal blood flow group (185 cases). Differences in serum RF and Cys-C levels and general clinical data were compared between the two groups. Analyzed the risk factors of no reflow after direct PCI in elderly patients with STEMI ,and analyzed the predictive value of RF and Cys-C for no reflow in patients. Results　The serum RF(18.34±7.65 IU/ml vs 8.47±4.16 IU/ml), Cys-C(1.58±0.54mg/L vs 0.87±0.32mg/ L) and number of stent implantation(3.15±1.43 vs 2.02±1.12), number of diseased vessels
[30(63.83%) vs 66(35.68%)] and diabetes
[33(70.21%) vs 77(41.62%)] rate of patients in the no-reflow group were significantly higher than those in the normal blood flow group， the difference was statistically significant(χ2/t=11.954~111.607，all P<0.05). Logistic multivariate regression analysis showed that age, diabetes, RF and Cys-C were risk predictors of no-reflow after direct PCI in elderly patients with STEMI (OR=1.893~3.025, all P<0.05). The receiver operating characteristic (ROC) area under curve (AUC) of RF and Cys-C predicted no-reflow after direct PCI in elderly patients with STEM were 0.864 and 0.821 respectively, and the AUC of the combined detection was 0.918, which was higher than either single index of RF and Cys-C. Conclusion　Serum RF and Cys-C levels of no-reflow after direct PCI in elderly patients with STEM were increased, and the two are risk factors for the occurrence of no-reflow, which is helpful for the early recognition of no-flow.

参考文献/References:

[1] 蔡文灿, 刘熙君, 刘彦明, 等. 血清PLGF和sFLT-1 水平联合检测对急性ST 段抬高型心肌梗死患者 PCI 术后MACE 复发的诊断价值研究[J]. 现代检验 医学杂志, 2021, 36(2):66-69. CAI Wencan, LIU Xijun, LIU Yanming, et al. Combined detection of serum PLGF and SFLT-1 levels in the diagnosis of MACE recurrence after PCI in patients with acute ST-segment elevation myocardial infarction[J]. Journal of Modern Laboratory Medicine , 2021, 36(2):66-69.
[2] 戴敬, 吕树铮, 宋现涛, 等. 介入术后无复流现象的 研究进展[J]. 心肺血管病杂志, 2014, 33(1):133-135. DAI Jing, L? Shuzheng, SONG Xiantao, et al. Research progress of no reflow phenomenon after interventional surgery[J]. Journal of Cardiovascular and Pulmonary Diseases, 2014, 33(1):133-135.
[3] GARCIA S, TERROSO G, GOMES A, et al. Aseptic hypertrophic pachymeningitis in a patient with Rheumatoid arthritis-a case of involvement of the central nervous system by the disease[J]. Acta Reumatologica Portuguesa, 2021, 46(1): 69-71.
[4] CHUNG Y K, LEE Y J, KIM K W, et al. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study[J]. Diabetes & Vascular Disease Research 2018, 15(1): 24-30.
[5] 曹亚丽, 姜志安, 王涛．经皮冠状动脉介入术后冠 状动脉无复流现象的研究进展[J]. 实用心脑肺血管 病杂志, 2018, 26(4):1-4. CAO Yali, JIANG Zhian, WANG Tao. Progress on coronary no-reflow phenomenon after percutaneous coronary intervention [J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease, 2018, 26(4):1-4.
[6] 中国医师协会急诊医师分会, 中华医学会心血管病 学分会, 中华医学会检验医学分会. 急性冠脉综合 征急诊快速诊疗指南[J]. 中华急诊医学杂志, 2016, 25(4):397-404. Emergency Medical Branch of Chinese Medical Doctor Association, Cardiovascular Epidemiology Branch of Chinese Medical Association, Laboratory Medicine Branch of Chinese Medical Associations. Emergency rapid diagnosis and treatment of guidelines acute coronary syndrome[J].Chinese Journal of Emergency Medicine, 2016, 25(4):397-404.
[7] AMIN S T, MORROW D A, BRAUNWALD E, et al. Dynamic TIMI risk score for STEMI[J]. Journal of the American Heart Association, 2013, 2(1): e003269.
[8] 丁琦, 王淑红, 冯晔子, 等. 急性ST 段抬高型心肌 梗死患者直接经皮冠脉介入治疗术中慢血流/ 无复 流的危险因素分析[J]. 中国循证心血管医学杂志, 2020, 12(3):364-369. DING Qi, WANG Shuhong, FENG Yezi, et al. Risk factors of slow / no reflow in patients with acute STsegment elevation myocardial infarction during direct percutaneous coronary intervention[J]. Chinese Journal of Evidence-Bases Cardiovascular Medicine, 2020, 12(3):364-369.
[9] 万尊慧, 王珍霞, 张城, 等. 急性心肌梗死经皮冠状 动脉介入术术后无复流相关因素的研究[J]. 吉林医 学, 2020, 41(1):198-202. WAN Zunhui, WANG Zhenxia, ZHANG Cheng, et al. The effect of percutaneous coronary intervention on reflux in patients with acute myocardial infarction[J]. Jilin Medical Journal, 2020, 41(1):198-202.
[10] 秦忠心, 钱进, 谢建, 等. 急性ST 段抬高型心肌梗 死患者急诊PCI 术后无复流相关因素分析[J]. 医学 与哲学, 2018, 39(12):28-31. QIN Zhongxin, QIAN Jin, XIE Jian, et al. Analysis of related factors of no reflow in patients with acute ST segment elevation myocardial infarction after emergency percutaneous coronary intervention[J]. Medicine & Philosophy, 2018, 39(12):28-31.
[11] 张文兰, 白力, 胡同平. 抗IgG，IgM，IgA 型心磷 脂抗体和抗β2 糖蛋白1 抗体在系统性红斑狼疮患 者中的意义[J]. 免疫学杂志, 2017, 33(1):59-62. ZHANG Wenlan, BAI Li, HU Tongping. Significance of anti-IgG, IgM, IgA cardiolipin antibodies and anti-β2 glycoprotein 1 antibody in patients with systemic lupus erythematosus[J]. Immunological Journal, 2017, 33(1):59- 62.
[12] WU Chaoyi, YANG Huangyu, LUO Shuefen, et al. From Rheumatoid factor to anti-citrullinated protein antibodies and anti-carbamylated protein antibodies for diagnosis and prognosis prediction in patients with Rheumatoid arthritis[J]. International Journal of Molecular Sciences, 2021, 22(2): 686.
[13] 高婷, 孙晓丽, 王岚, 等. 类风湿性关节炎患者心血 管并发症与脂蛋白a 的相关性研究进展[J]. 现代生 物医学进展, 2017, 17(17):3389-3392. GAO Ting, SUN Xiaoli, WANG Lan, et al. Research progress on the association between cardiovascular complications and lipoprotein(a) in Rheumatoid arthritis patients [J]. Progress in Modern Biomedicine, 2017, 17(17):3389-3392.
[14] 应佐华, 马晓峰, 杨良瑞, 等. 类风湿因子水平在冠 心病PCI 治疗患者中的临床意义[J]. 中国临床研究, 2020, 33(1):31-34. YING Zuohua, MA Xiaofeng, YANG Liangrui, et al. Clinical significance of Rheumatoid factor levels in patients with coronary heart disease treated by PCI [J]. Chinese Journal of Clinical Research, 2020, 33(1):31-34.
[15] LI Chuang, WANG Yuxing, ZHANG Qian, et al. Incorporating the erythrocyte sedimentation rate for enhanced accuracy of the global registry of acute coronary event score in patients with ST-segment elevated myocardial infarction: A retrospective cohort study[J]. Medicine, 2020, 99(41) : e22523.
[16] QUISI A, ALICI G. The relationship between serum Rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Journal of Clinical Laboratory Analysis, 2018, 32(9): e22598.
[17] FALKENBURG W, OSKAM N, KOERS J, et al. Identification of clinically and pathophysiologically relevant Rheumatoid factor epitopes by engineered IgG targets[J]. Arthritis & Rheumatology (Hoboken, N.J.), 2020, 72(12): 2005-2016.
[18] 王璐, 李维娟, 杨靖．血清NT-proBNP 和Cys-C 水 平联合检测在心力衰竭诊断与分型中的应用[J]．现 代检验医学杂志,2018,33(6):91-94. WANG Lu, LI Weijuan, YANG Jing. Application of combined detection of serum NT-proBNP and Cys-C levels in diagnosis and typing of heart failure [J]. Journal of Modern Laboratory Medicine,2018,33(6):91-94.
[19] 李丹. 血清胱抑素 C 与 ACS 患者 PCI 术后主要不良 心血管事件的关系[J]. 心血管康复医学杂志, 2019, 28(4):437-441. LI Dan. Relationship between serum Cys C level and incidence of MACE in ACS patients after PCI [J]. Chinese Journal of Cardiovascular Rehabilitation Medicine, 2019, 28(4):437-441.
[20] 邵冰, 吴蔚, 王晓萍. 冠心病患者支架植入术前后血 清胱抑素C 水平的变化及其意义[J]. 中国全科医学, 2015, 18(5):585-587. SHAO Bing, WU Wei, WANG Xiaoping. Clinical changes of serum Cystatin C before and after PCI and its significance [J]. Chinese General Practice, 2015, 18(5):585-587.
[21] CHENG Chao, LIU Xiaobo, BI Shaojie , et al. Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.[J]. PLoS One, 2019, 14(8) : e0220654.
[22] ARPEGARD J, VIKTORIN A, CHANG Zheng, et al. Comparison of heritability of cystatin C and creatininebased estimates of kidney function and their relation to heritability of cardiovascular disease[J]. Journal of the American Heart Association, 2015, 4(1) : e001467.
[23] TANG Liang, FANG Zhenfei, ZHOU Shenghua, et al. Association of serum cystatin C levels with myocardial perfusion and cardiac functional recovery in patients with anterior wall ST elevation myocardial infarction treated with primary coronary intervention[J]. Heart and Vessels, 2016, 31(9): 1456-1466.

相似文献/References:

[1]赵辉.抗CCP抗体，AKA与RF联合检测在类风湿关节炎诊断中的临床意义[J].现代检验医学杂志,2015,30(05):159.[doi:10.3969/j.issn.1671-7414.2015.05.051]
　ZHAO Hui.Clinical Significance of Anti-CCP Antibody and Anti-AKA Antibody and Rheumatoid Factor in Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2015,30(02):159.[doi:10.3969/j.issn.1671-7414.2015.05.051]
[2]卢春利,刘小玲,曹团平,等.幼年类风湿关节炎患者中抗CCP抗体和RF，AKA，APF的相关性分析[J].现代检验医学杂志,2015,30(06):136.[doi:10.3969/j.issn.1671-7414.2015.06.042]
　LU Chun-li,LIU Xiao-ling,CAO Tuan-ping,et al.Analysis on the Correlation of Anti-CCP Antibody and RF，AKA，APF in JRA[J].Journal of Modern Laboratory Medicine,2015,30(02):136.[doi:10.3969/j.issn.1671-7414.2015.06.042]
[3]冯 婧,喻晓雯,吴 斌,等.血清多项自身抗体检测对类风湿关节炎的诊断价值[J].现代检验医学杂志,2019,34(05):9.[doi:10.3969/j.issn.1671-7414.2019.05.003]
　FENG Jing,YU Xiao-wen,WU Bin,et al.Diagnostic Value of Serum Multiple Autoantibodies in Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2019,34(02):9.[doi:10.3969/j.issn.1671-7414.2019.05.003]
[4]陈建芸a,廖海平a,孙朝晖a,等.类风湿性关节炎患者血清RA-CP，抗CCP 抗体及RF 检测对RA 的实验诊断意义[J].现代检验医学杂志,2020,35(05):38.[doi:10.3969/j.issn.1671-7414.2020.05.010]
　CHEN Jian-yuna,LIAO Hai-pinga,SUN Zhao-huia,et al.Significance of the Detection of RA-CP, Anti-CCP Antibody and RF in the Laboratory Diagnosis of Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2020,35(02):38.[doi:10.3969/j.issn.1671-7414.2020.05.010]
[5]蔡文灿,刘熙君,刘彦明,等.血清PLGF和sFLT-1水平联合检测对急性ST段抬高型心肌梗死患者PCI术后MACE复发的诊断价值研究[J].现代检验医学杂志,2021,36(02):66.[doi:doi:10.3969/j.issn.1671-7414.2021.02.016]
　CAI Wen-can,LIU Xi-jun,LIU Yan-ming,et al.Combined Detection of Serum PLGF and SFLT-1 Levels in the Diagnosis of MACE Recurrence after PCI in Patients with Acute ST-segment Elevation Myocardial Infarction[J].Journal of Modern Laboratory Medicine,2021,36(02):66.[doi:doi:10.3969/j.issn.1671-7414.2021.02.016]
[6]雷明玲,彭常基,张肄鹏,等.深圳地区类风湿关节炎患者 IL-17A 基因 rs2275913 位点多态性与血清中 IL-17A，IL-38 水平表达的相关性研究[J].现代检验医学杂志,2021,36(03):19.[doi:10.3969/j.issn.1671-7414.2021.03.005]
　LEI Ming-ling,PENG Chang-ji,ZHANG Yi-peng,et al.Study on the Correlation between rs2275913 Polymorphism of IL-17A Geneand Serum IL-17A and IL-38 Expression in Patients with RheumatoidArthritis in Shenzhen Area[J].Journal of Modern Laboratory Medicine,2021,36(02):19.[doi:10.3969/j.issn.1671-7414.2021.03.005]

备注/Memo

备注/Memo:
基金项目： 河北省2020 年度医学科学研究课题计划项目（20202482）。
作者简介：孙莹莹(1984-)，女，本科，主治医师，研究方向：心血管疾病诊治，E-mail：tqw966@163.com。
更新日期/Last Update: 1900-01-01